Annual SG&A
$87.50 M
+$18.65 M+27.08%
31 December 2023
Summary:
Pharming Group NV annual selling, general & administrative expenses is currently $87.50 million, with the most recent change of +$18.65 million (+27.08%) on 31 December 2023. During the last 3 years, it has risen by +$22.50 million (+34.62%). PHAR annual SG&A is now at all-time high.PHAR Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$43.98 M
-$4.57 M-9.41%
30 September 2024
Summary:
Pharming Group NV quarterly selling, general & administrative expenses is currently $43.98 million, with the most recent change of -$4.57 million (-9.41%) on 30 September 2024. Over the past year, it has increased by +$7.97 million (+22.13%). PHAR quarterly SG&A is now -9.41% below its all-time high of $48.55 million, reached on 30 June 2024.PHAR Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.10 B
-$15.60 M-1.44%
30 September 2024
Summary:
Pharming Group NV TTM selling, general & administrative expenses is currently -$1.10 billion, with the most recent change of -$15.60 million (-1.44%) on 30 September 2024. Over the past year, it has dropped by -$1.20 billion (-1184.02%). PHAR TTM SG&A is now -243.22% below its all-time high of $107.38 million, reached on 30 September 2024.PHAR TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.1% | +22.1% | -1184.0% |
| 3 y3 years | +34.6% | +94.2% | -1518.2% |
| 5 y5 years | +86.8% | +227.8% | -2227.0% |
PHAR Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +81.8% | -9.4% | +244.3% | -8.1% | +2.6% |
| 5 y | 5 years | at high | +86.8% | -9.4% | +244.3% | -8.1% | +24.0% |
| alltime | all time | at high | +3099.5% | -9.4% | +244.3% | -243.2% | +34.1% |
Pharming Group NV Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $43.98 M(-9.4%) | $107.38 M(+8.0%) |
| June 2024 | - | $48.55 M(+7.1%) | $99.41 M(+3.8%) |
| Mar 2024 | - | $45.34 M(-248.7%) | $95.75 M(+9.4%) |
| Dec 2023 | $87.50 M(+27.1%) | -$30.48 M(-184.7%) | $87.50 M(-13.9%) |
| Sept 2023 | - | $36.01 M(-19.8%) | $101.57 M(+3.7%) |
| June 2023 | - | $44.89 M(+21.0%) | $97.96 M(+20.9%) |
| Mar 2023 | - | $37.09 M(-326.0%) | $81.02 M(+17.7%) |
| Dec 2022 | $68.85 M(+43.1%) | -$16.41 M(-150.7%) | $68.85 M(+2.8%) |
| Sept 2022 | - | $32.40 M(+15.9%) | $67.00 M(+17.0%) |
| June 2022 | - | $27.95 M(+12.1%) | $57.25 M(+12.1%) |
| Mar 2022 | - | $24.93 M(-236.5%) | $51.05 M(+6.1%) |
| Dec 2021 | $48.13 M(-26.0%) | -$18.27 M(-180.7%) | $48.13 M(-38.0%) |
| Sept 2021 | - | $22.64 M(+4.1%) | $77.64 M(+4.9%) |
| June 2021 | - | $21.75 M(-1.1%) | $73.98 M(+7.9%) |
| Mar 2021 | - | $22.00 M(+95.6%) | $68.60 M(+5.5%) |
| Dec 2020 | $65.00 M(+16.3%) | $11.25 M(-40.8%) | $65.00 M(+0.3%) |
| Sept 2020 | - | $18.99 M(+16.1%) | $64.82 M(+9.4%) |
| June 2020 | - | $16.36 M(-11.1%) | $59.24 M(-1.6%) |
| Mar 2020 | - | $18.40 M(+66.3%) | $60.20 M(+7.7%) |
| Dec 2019 | $55.88 M(+19.3%) | $11.06 M(-17.5%) | $55.88 M(+7.9%) |
| Sept 2019 | - | $13.42 M(-22.6%) | $51.77 M(-2.0%) |
| June 2019 | - | $17.32 M(+23.1%) | $52.83 M(+10.6%) |
| Mar 2019 | - | $14.08 M(+102.5%) | $47.76 M(+2.0%) |
| Dec 2018 | $46.84 M(+4.4%) | $6.95 M(-52.0%) | $46.84 M(-17.8%) |
| Sept 2018 | - | $14.48 M(+18.1%) | $57.01 M(+4.6%) |
| June 2018 | - | $12.26 M(-6.8%) | $54.53 M(+4.1%) |
| Mar 2018 | - | $13.15 M(-23.2%) | $52.37 M(+16.7%) |
| Dec 2017 | $44.86 M(+455.7%) | $17.13 M(+42.9%) | $44.86 M(+43.4%) |
| Sept 2017 | - | $11.99 M(+18.7%) | $31.29 M(+49.9%) |
| June 2017 | - | $10.10 M(+78.8%) | $20.88 M(+68.2%) |
| Mar 2017 | - | $5.65 M(+59.0%) | $12.41 M(+53.7%) |
| Dec 2016 | $8.07 M | $3.55 M(+125.1%) | $8.07 M(+40.8%) |
| Sept 2016 | - | $1.58 M(-3.3%) | $5.74 M(+4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | $1.63 M(+24.4%) | $5.52 M(+2.4%) |
| Mar 2016 | - | $1.31 M(+8.2%) | $5.39 M(+2.0%) |
| Dec 2015 | $5.28 M(+30.6%) | $1.21 M(-10.7%) | $5.28 M(-9.9%) |
| Sept 2015 | - | $1.36 M(-9.8%) | $5.86 M(+7.9%) |
| June 2015 | - | $1.50 M(+24.9%) | $5.43 M(+23.1%) |
| Mar 2015 | - | $1.20 M(-33.0%) | $4.41 M(+9.2%) |
| Dec 2014 | $4.04 M(+16.2%) | $1.80 M(+93.8%) | $4.04 M(+20.4%) |
| Sept 2014 | - | $926.70 K(+90.8%) | $3.36 M(+3.7%) |
| June 2014 | - | $485.80 K(-41.7%) | $3.24 M(-8.4%) |
| Mar 2014 | - | $833.40 K(-24.9%) | $3.53 M(+1.7%) |
| Dec 2013 | $3.48 M(-18.6%) | $1.11 M(+37.6%) | $3.48 M(+5.0%) |
| Sept 2013 | - | $806.90 K(+2.9%) | $3.31 M(-5.1%) |
| June 2013 | - | $783.90 K(+1.0%) | $3.49 M(-7.5%) |
| Mar 2013 | - | $776.00 K(-18.0%) | $3.77 M(-11.6%) |
| Dec 2012 | $4.27 M(-23.4%) | $946.10 K(-4.0%) | $4.27 M(-22.1%) |
| Sept 2012 | - | $986.00 K(-7.5%) | $5.48 M(+1.2%) |
| June 2012 | - | $1.07 M(-16.3%) | $5.42 M(-3.1%) |
| Mar 2012 | - | $1.27 M(-41.0%) | $5.59 M(+0.2%) |
| Dec 2011 | $5.57 M(+30.6%) | $2.16 M(+134.2%) | $5.57 M(+32.7%) |
| Sept 2011 | - | $921.30 K(-25.5%) | $4.20 M(-2.2%) |
| June 2011 | - | $1.24 M(-1.8%) | $4.29 M(+5.1%) |
| Mar 2011 | - | $1.26 M(+60.8%) | $4.08 M(+1.9%) |
| Dec 2010 | $4.27 M(-16.6%) | $783.20 K(-22.8%) | $4.01 M(-8.9%) |
| Sept 2010 | - | $1.01 M(-1.4%) | $4.40 M(-7.4%) |
| June 2010 | - | $1.03 M(-13.0%) | $4.75 M(-9.2%) |
| Mar 2010 | - | $1.18 M(+0.7%) | $5.23 M(+4.4%) |
| Dec 2009 | $5.11 M(+11.3%) | $1.17 M(-14.2%) | $5.01 M(+30.6%) |
| Sept 2009 | - | $1.37 M(-9.3%) | $3.83 M(+55.5%) |
| June 2009 | - | $1.51 M(+57.1%) | $2.47 M(+157.1%) |
| Mar 2009 | - | $959.20 K | $959.20 K |
| Dec 2008 | $4.60 M(+11.6%) | - | - |
| Dec 2007 | $4.12 M(+11.1%) | - | - |
| Dec 2006 | $3.71 M(+35.5%) | - | - |
| Dec 2005 | $2.73 M | - | - |
FAQ
- What is Pharming Group NV annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Pharming Group NV?
- What is Pharming Group NV annual SG&A year-on-year change?
- What is Pharming Group NV quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Pharming Group NV?
- What is Pharming Group NV quarterly SG&A year-on-year change?
- What is Pharming Group NV TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Pharming Group NV?
- What is Pharming Group NV TTM SG&A year-on-year change?
What is Pharming Group NV annual selling, general & administrative expenses?
The current annual SG&A of PHAR is $87.50 M
What is the all time high annual SG&A for Pharming Group NV?
Pharming Group NV all-time high annual selling, general & administrative expenses is $87.50 M
What is Pharming Group NV annual SG&A year-on-year change?
Over the past year, PHAR annual selling, general & administrative expenses has changed by +$18.65 M (+27.08%)
What is Pharming Group NV quarterly selling, general & administrative expenses?
The current quarterly SG&A of PHAR is $43.98 M
What is the all time high quarterly SG&A for Pharming Group NV?
Pharming Group NV all-time high quarterly selling, general & administrative expenses is $48.55 M
What is Pharming Group NV quarterly SG&A year-on-year change?
Over the past year, PHAR quarterly selling, general & administrative expenses has changed by +$7.97 M (+22.13%)
What is Pharming Group NV TTM selling, general & administrative expenses?
The current TTM SG&A of PHAR is -$1.10 B
What is the all time high TTM SG&A for Pharming Group NV?
Pharming Group NV all-time high TTM selling, general & administrative expenses is $107.38 M
What is Pharming Group NV TTM SG&A year-on-year change?
Over the past year, PHAR TTM selling, general & administrative expenses has changed by -$1.20 B (-1184.02%)